Pages

▼
Thursday, April 17, 2025

The AI Advantage: When and Where to Apply It in Your Patient Support Program

›
Today’s guest post comes from William Grambley, Chief Product Officer at AssistRx.   William discusses four specific use cases for how AI...
Wednesday, April 16, 2025

The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market

›
Drug Channels Institute’s (DCI’s) latest analysis reveals that PBM-affiliated specialty pharmacies continue to dominate the dispensing of sp...
Tuesday, April 15, 2025

Master the Hidden Economics of Pharmaceuticals—In Under an Hour—with DCI's New eLearning Modules

›
In today’s fast-moving pharmaceutical marketplace, insight is everything. Whether you're building trust with customers, launching new pr...
Friday, April 11, 2025

The Hidden Costs of Data Silos: How Pharma Manufacturers Can Stop Revenue Leaks and Strengthen Security

›
Today’s guest post comes from Jim Hundemer, Chief Information Security Officer (CISO), and Sudhakar Velamoor, Chief Technology Officer (CT...
Wednesday, April 09, 2025

Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: DCI’s 2025 Update and Competitive Outlook

›
It's time for Drug Channels ’ annual update of vertical integration among insurers, PBMs, specialty pharmacies, and healthcare services ...
Friday, April 04, 2025

Inflation-Adjusted U.S. Brand-Name Drug Prices Fell for the Seventh Consecutive Year as a New Era of Drug Pricing Dawns (rerun)

›
This week, I’m rerunning some popular posts while I prepare for today’s live video webinar: PBM Industry Update: Trends, Challenges, and Wha...
Thursday, April 03, 2025

Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (rerun)

›
This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: PBM Industry Update: Trends, Challenges, and ...
Wednesday, April 02, 2025

Four Revelations from Minnesota’s First 340B Transparency Report (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: PBM Industry Update: Trends, Challenges, and Wh...
Tuesday, April 01, 2025

The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: PBM Industry Update: Trends, Challenges, and Wh...
Monday, March 31, 2025

The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments

›
Three’s still company in the world of pharmacy benefit managers. For 2024, nearly 80% of all equivalent prescription claims were processed ...
Friday, March 28, 2025

The New Playbook for Patient Support Programs: Flexibility, Focus, and Forward-Thinking

›
Today’s guest post comes from Josh Marsh, Vice President and General Manager, Sonexus™ Access and Patient Support at Cardinal Health. Jos...
Wednesday, March 26, 2025

Drug Channels News Roundup, March 2025: PBM Unbundling Update, Stelara Biosimilar Price War, My $0.02 on the Optum Rx News, Follow the Dollar, and #DCLF2025

›
Spring has officially arrived in sunny downtown Philadelphia—the proud home base of Drug Channels . As you can see on the right, we celebrat...